These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8305357

  • 1. Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study.
    Money-Kyrle JF, Bates F, Ready J, Gazzard BG, Phillips RH, Boag FC.
    Clin Oncol (R Coll Radiol); 1993; 5(6):367-71. PubMed ID: 8305357
    [Abstract] [Full Text] [Related]

  • 2. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
    Girard PM, Bouchaud O, Goetschel A, Mukwaya G, Eestermans G, Ross M, Rozenbaum W, Saimot AG.
    AIDS; 1996 Jun; 10(7):753-7. PubMed ID: 8805866
    [Abstract] [Full Text] [Related]

  • 4. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
    Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM.
    J Clin Oncol; 1995 Apr; 13(4):996-1003. PubMed ID: 7707129
    [Abstract] [Full Text] [Related]

  • 5. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma.
    Presant CA, Scolaro M, Kennedy P, Blayney DW, Flanagan B, Lisak J, Presant J.
    Lancet; 1993 May 15; 341(8855):1242-3. PubMed ID: 8098393
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin.
    Schürmann D, Dormann A, Grünewald T, Ruf B.
    Eur Respir J; 1994 Apr 15; 7(4):824-5. PubMed ID: 8005268
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.
    Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS.
    J Clin Oncol; 1998 Oct 15; 16(10):3369-74. PubMed ID: 9779714
    [Abstract] [Full Text] [Related]

  • 8. Liposomal chemotherapies.
    Smart T.
    GMHC Treat Issues; 1995 Oct 15; 9(7/8):13. PubMed ID: 11362653
    [Abstract] [Full Text] [Related]

  • 9. Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission.
    Prescrire Int; 1998 Apr 15; 7(34):41-2. PubMed ID: 10183380
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma.
    Bennett CL, Golub RM, Stinson TJ, Aboulafia DM, von Roenn J, Bogner J, Goebel FD, Stewart S.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug 15; 18(5):460-5. PubMed ID: 9715842
    [Abstract] [Full Text] [Related]

  • 11. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.
    Cabriales S, Bresnahan J, Testa D, Espina BM, Scadden DT, Ross M, Gill PS.
    Oncol Nurs Forum; 1998 Aug 15; 25(1):67-70. PubMed ID: 9460774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
    Coukell AJ, Spencer CM.
    Drugs; 1997 Mar 15; 53(3):520-38. PubMed ID: 9074848
    [Abstract] [Full Text] [Related]

  • 14. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK, Miller RF, Spittle MF.
    Clin Oncol (R Coll Radiol); 1993 Mar 15; 5(6):372-4. PubMed ID: 8305358
    [Abstract] [Full Text] [Related]

  • 15. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr 15; 10(4):8-9. PubMed ID: 11363710
    [Abstract] [Full Text] [Related]

  • 16. Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma.
    Am J Health Syst Pharm; 1996 Jul 01; 53(13):1500, 1505. PubMed ID: 8809269
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan 01; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 18. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May 03; (no 246):3-4. PubMed ID: 11363485
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of liposomal daunorubicin and its use in Kaposi's sarcoma.
    Chew T, Jacobs M.
    Oncology (Williston Park); 1996 Jun 03; 10(6 Suppl):28-33; discussion 37-8. PubMed ID: 16871707
    [Abstract] [Full Text] [Related]

  • 20. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
    Saiag P, Pavlovic M, Clerici T, Feauveau V, Nicolas JC, Emile D, Chastang C.
    AIDS; 1998 Nov 12; 12(16):2169-76. PubMed ID: 9833858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.